Health
Nutriband seeks dual listing as it nears market launch for fentanyl patch
Nasdaq-listed pharma company seeks Upstream listing ahead of FDA approval for its Aversa-based abuse deterrent patches
Nasdaq-listed pharma company seeks Upstream listing ahead of FDA approval for its Aversa-based abuse deterrent patches